The board of directors for Baton Rouge-based home health and hospice firm Amedisys has approved a stock buyback plan, by which the company can opt to repurchase up to $75 million of its outstanding co…
Already an INSIDER? Sign in.
Amedisys board OK’s $75M stock buyback plan
